31 related articles for article (PubMed ID: 38767518)
1. Treatment intensity affects immune reconstitution even after childhood cancer not treated with hematopoietic stem cell transplantation.
Antikainen E; Grönroos M; Huurre A; Korhonen L; Peltola V; Lähteenmäki P; Schuez-Havupalo L
Cancer Rep (Hoboken); 2024 May; 7(5):e2069. PubMed ID: 38767518
[TBL] [Abstract][Full Text] [Related]
2. Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34
Salzmann-Manrique E; Bremm M; Huenecke S; Stech M; Orth A; Eyrich M; Schulz A; Esser R; Klingebiel T; Bader P; Herrmann E; Koehl U
Front Immunol; 2018; 9():1841. PubMed ID: 30154788
[TBL] [Abstract][Full Text] [Related]
3. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
[TBL] [Abstract][Full Text] [Related]
4. Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ
Diaz MA; Zubicaray J; Molina B; Abad L; Castillo A; Sebastian E; Galvez E; Ruiz J; Vicario JL; Ramirez M; Sevilla J; González-Vicent M
Front Immunol; 2019; 10():2504. PubMed ID: 31736949
[TBL] [Abstract][Full Text] [Related]
5. Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.
Varda-Bloom N; Danylesko I; Shouval R; Eldror S; Lev A; Davidson J; Rosenthal E; Volchek Y; Shem-Tov N; Yerushalmi R; Shimoni A; Somech R; Nagler A
Oncotarget; 2017 Jan; 8(1):418-429. PubMed ID: 27880933
[TBL] [Abstract][Full Text] [Related]
6. Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients.
Bhatt ST; Bednarski JJ; Berg J; Trinkaus K; Murray L; Hayashi R; Schulz G; Hente M; Grimley M; Chan KW; Kamani N; Jacobsohn D; Nieder M; Hale G; Yu L; Adams R; Dalal J; Pulsipher MA; Haut P; Chaudhury S; Davis J; Jaroscak J; Andreansky M; Willert J; Shenoy S
Biol Blood Marrow Transplant; 2019 Mar; 25(3):556-561. PubMed ID: 30321596
[TBL] [Abstract][Full Text] [Related]
7. Temporal evolution and differential patterns of cellular reconstitution after therapy for childhood cancers.
Hofmann G; Zierk J; Sobik B; Wotschofsky Z; Sembill S; Krumbholz M; Metzler M; Karow A
Sci Rep; 2023 Mar; 13(1):4022. PubMed ID: 36899075
[TBL] [Abstract][Full Text] [Related]
8. Immune function in childhood cancer survivors: a Children's Oncology Group review.
Guilcher GMT; Rivard L; Huang JT; Wright NAM; Anderson L; Eissa H; Pelletier W; Ramachandran S; Schechter T; Shah AJ; Wong K; Chow EJ
Lancet Child Adolesc Health; 2021 Apr; 5(4):284-294. PubMed ID: 33600774
[TBL] [Abstract][Full Text] [Related]
9. Immunological Reconstitution in Children After Completing Conventional Chemotherapy of Acute Lymphoblastic Leukemia is Marked by Impaired B-cell Compartment.
Koskenvuo M; Ekman I; Saha E; Salokannel E; Matomäki J; Ilonen J; Kainulainen L; Arola M; Lähteenmäki PM
Pediatr Blood Cancer; 2016 Sep; 63(9):1653-6. PubMed ID: 27163649
[TBL] [Abstract][Full Text] [Related]
10. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
Jakacki RI; Cohen KJ; Buxton A; Krailo MD; Burger PC; Rosenblum MK; Brat DJ; Hamilton RL; Eckel SP; Zhou T; Lavey RS; Pollack IF
Neuro Oncol; 2016 Oct; 18(10):1442-50. PubMed ID: 27006176
[TBL] [Abstract][Full Text] [Related]
11. Impaired B-cell reconstitution in children after chemotherapy for standard or medium risk acute precursor B-lymphoblastic leukemia.
Wiegering V; Frank J; Freudenberg S; Morbach H; Schlegel PG; Eyrich M; Winkler B
Leuk Lymphoma; 2014 Apr; 55(4):870-5. PubMed ID: 23786458
[TBL] [Abstract][Full Text] [Related]
12. A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment.
Kazak AE; Hocking MC; Ittenbach RF; Meadows AT; Hobbie W; DeRosa BW; Leahey A; Kersun L; Reilly A
Pediatr Blood Cancer; 2012 Jul; 59(1):96-9. PubMed ID: 21858914
[TBL] [Abstract][Full Text] [Related]
13. Immune reconstitution in children following chemotherapy for haematological malignancies: a long-term follow-up.
van Tilburg CM; van Gent R; Bierings MB; Otto SA; Sanders EA; Nibbelke EE; Gaiser JF; Janssens-Korpela PL; Wolfs TF; Bloem AC; Borghans JA; Tesselaar K
Br J Haematol; 2011 Jan; 152(2):201-10. PubMed ID: 21114483
[TBL] [Abstract][Full Text] [Related]
14. Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: impact on lymphocyte compartment composition.
van Tilburg CM; van der Velden VH; Sanders EA; Wolfs TF; Gaiser JF; de Haas V; Pieters R; Bloem AC; Bierings MB
Leuk Res; 2011 Apr; 35(4):484-91. PubMed ID: 21051085
[TBL] [Abstract][Full Text] [Related]
15. Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 paediatric patients.
Eyrich M; Wiegering V; Lim A; Schrauder A; Winkler B; Schlegel PG
Br J Haematol; 2009 Nov; 147(3):360-70. PubMed ID: 19694715
[TBL] [Abstract][Full Text] [Related]
16. Late immune recovery in children treated for malignant diseases.
Kovacs GT; Barany O; Schlick B; Csoka M; Gado J; Ponyi A; Müller J; Nemeth J; Hauser P; Erdelyi DJ
Pathol Oncol Res; 2008 Dec; 14(4):391-7. PubMed ID: 18575827
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL.
Kosmidis S; Baka M; Bouhoutsou D; Doganis D; Kallergi C; Douladiris N; Pourtsidis A; Varvoutsi M; Saxoni-Papageorgiou F; Vasilatou-Kosmidis H
Pediatr Blood Cancer; 2008 Mar; 50(3):528-32. PubMed ID: 17853465
[TBL] [Abstract][Full Text] [Related]
18. [The function of the immune system after the treatment of pediatric malignant diseases].
Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
